These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30004223)

  • 1. Synthesis of Chiral cis-Cyclopropane Bearing Indole and Chromone as Potential TNFα Inhibitors.
    Kanada R; Tanabe M; Muromoto R; Sato Y; Kuwahara T; Fukuda H; Arisawa M; Matsuda T; Watanabe M; Shuto S
    J Org Chem; 2018 Aug; 83(15):7672-7682. PubMed ID: 30004223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units: synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine.
    Kazuta Y; Matsuda A; Shuto S
    J Org Chem; 2002 Mar; 67(5):1669-77. PubMed ID: 11871901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of chiral bromomethylenecyclopropane and its use in Suzuki-Miyaura coupling: synthesis of the arylmethyl-(Z)-cyclopropane structure core.
    Tanabe M; Watanabe M; Hoshiya N; Mizuno A; Fukuda H; Arisawa M; Shuto S
    J Org Chem; 2013 Dec; 78(23):11714-20. PubMed ID: 24206361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkene isomerization/enamide-ene and diene metathesis for the construction of indoles, quinolines, benzofurans and chromenes with a chiral cyclopropane substituent.
    Kobayashi T; Arisawa M; Shuto S
    Org Biomol Chem; 2011 Feb; 9(4):1219-24. PubMed ID: 21180704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a cis-cyclopropane via reductive radical decarboxylation. Enantioselective synthesis of cis- and trans-1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents.
    Yamaguchi K; Kazuta Y; Abe H; Matsuda A; Shuto S
    J Org Chem; 2003 Nov; 68(24):9255-62. PubMed ID: 14629144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of cyclopropane-based conformationally restricted GABA analogues as selective inhibitors for betaine/GABA transporter 1.
    Suemasa A; Watanabe M; Kobayashi T; Suzuki H; Fukuda H; Minami M; Shuto S
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3395-3399. PubMed ID: 30177378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.
    Mattson RJ; Catt JD; Denhart DJ; Deskus JA; Ditta JL; Higgins MA; Marcin LR; Sloan CP; Beno BR; Gao Q; Cunningham MA; Mattson GK; Molski TF; Taber MT; Lodge NJ
    J Med Chem; 2005 Sep; 48(19):6023-34. PubMed ID: 16162005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-free Suzuki-Miyaura coupling with sulfur-modified gold-supported palladium in the synthesis of a conformationally-restricted cyclopropane compound library with three-dimensional diversity.
    Arisawa M; Sato T; Hoshiya N; Al-Amin M; Kogami Y; Shuto S
    ACS Comb Sci; 2014 May; 16(5):215-20. PubMed ID: 24697302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhodium(II) acetate-catalyzed stereoselective synthesis, SAR and anti-HIV activity of novel oxindoles bearing cyclopropane ring.
    Kumari G; Nutan ; Modi M; Gupta SK; Singh RK
    Eur J Med Chem; 2011 Apr; 46(4):1181-8. PubMed ID: 21339030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of All-cis-substituted Cyclopropane and Total Synthesis of Avenaol].
    Yasui M
    Yakugaku Zasshi; 2019; 139(10):1259-1265. PubMed ID: 31582609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantio- and diastereocontrolled conversion of chiral epoxides to trans-cyclopropane carboxylates: application to the synthesis of cascarillic acid, grenadamide and L-(-)-CCG-II.
    Kumar P; Dubey A; Harbindu A
    Org Biomol Chem; 2012 Sep; 10(34):6987-94. PubMed ID: 22832742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective synthesis of 1,2,3-trisubstituted cyclopropanes using gem-dizinc reagents.
    Zimmer LE; Charette AB
    J Am Chem Soc; 2009 Nov; 131(43):15624-6. PubMed ID: 19813709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladium-catalyzed arylation of cyclopropanes via directing group-mediated C(sp3)-H bond activation to construct quaternary carbon centers: synthesis of cis- and trans-1,1,2-trisubstituted chiral cyclopropanes.
    Hoshiya N; Kobayashi T; Arisawa M; Shuto S
    Org Lett; 2013 Dec; 15(24):6202-5. PubMed ID: 24279330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel strategy for the asymmetric synthesis of chiral cyclopropane carboxaldehydes.
    Cheeseman M; Feuillet FJ; Johnson AL; Bull SD
    Chem Commun (Camb); 2005 May; (18):2372-4. PubMed ID: 15877132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 1-arylpiperazyl-2-phenylcyclopropanes designed as antidopaminergic agents: cyclopropane-based conformationally restricted analogs of haloperidol.
    Yamaguchi K; Kazuta Y; Hirano K; Yamada S; Matsuda A; Shuto S
    Bioorg Med Chem; 2008 Oct; 16(19):8875-81. PubMed ID: 18793859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclopropane-derived peptidomimetics. Design, synthesis, and evaluation of novel enkephalin analogues.
    Martin SF; Dwyer MP; Hartmann B; Knight KS
    J Org Chem; 2000 Mar; 65(5):1305-18. PubMed ID: 10814090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient chemo-enzymatic synthesis and 18F-labelling of both enantiomers of trans-1-toluenesulfonyloxymethyl-2-fluoromethyl-cyclopropane.
    Riss PJ; Rösch F
    Org Biomol Chem; 2008 Dec; 6(24):4567-74. PubMed ID: 19039365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.